Gene · 8493
Papers2,396
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,396
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chimeric Antigen Receptor (CAR) T-cell Therapy in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL): A Systematic Review. | Cureus | 2024 | 39822464 | PubTator, text mining | PubMed |
| Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational study. | EClinicalMedicine | 2024 | 39764177 | PubTator, text mining | PubMed |
| PP2C phosphatases-terminators of suicidal thoughts. | Cell Death Dis | 2024 | 39702569 | PubTator, text mining | PubMed |
| How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case report. | Ann Transl Med | 2024 | 39507461 | PubTator, text mining | PubMed |
| PPM1D/Wip1 is amplified, overexpressed, and mutated in human non-Hodgkin's lymphomas. | Mol Biol Rep | 2024 | 39489796 | PubTator, text mining | PubMed |
| Clonal dynamics after allogeneic haematopoietic cell transplantation. | Nature | 2024 | 39478227 | PubTator, text mining | PubMed |
| Genetic variants in patients with multiple arterial aneurysms. | Langenbecks Arch Surg | 2024 | 39382597 | PubTator, text mining | PubMed |
| CHIP shot: aiming at therapy-induced clonal hematopoiesis. | Blood Adv | 2024 | 39378028 | PubTator, text mining | PubMed |
| Distinct landscape and clinical implications of therapy-related clonal hematopoiesis. | J Clin Invest | 2024 | 39352380 | PubTator, text mining | PubMed |
| Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations. | Blood | 2024 | 39316766 | PubTator, text mining | PubMed |
| PPM1D activity promotes cellular transformation by preventing senescence and cell death. | Oncogene | 2024 | 39237765 | PubTator, text mining | PubMed |
| Mutational Landscapes of Normal Skin and Their Potential Implications in the Development of Skin Cancer: A Comprehensive Narrative Review. | J Clin Med | 2024 | 39200957 | PubTator, text mining | PubMed |
| Rising Prevalence of Low-Frequency PPM1D Gene Mutations after Second HDCT in Multiple Myeloma. | Curr Issues Mol Biol | 2024 | 39194701 | PubTator, text mining | PubMed |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. | Cancer Genomics Proteomics | 2024 | 39191493 | PubTator, text mining | PubMed |
| Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China. | Int J Cancer | 2024 | 39109820 | PubTator, text mining | PubMed |
| Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging cases. | Clin Exp Med | 2024 | 39042228 | PubTator, text mining | PubMed |
| Crystal structure and mechanistic studies of the PPM1D serine/threonine phosphatase catalytic domain. | J Biol Chem | 2024 | 39002674 | PubTator, text mining | PubMed |
| WIP1-mediated regulation of p38 MAPK signaling attenuates pyroptosis in sepsis-associated acute kidney injury. | Immunobiology | 2024 | 38943814 | PubTator, text mining | PubMed |
| SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells. | Elife | 2024 | 38896450 | PubTator, text mining | PubMed |
| Retraction Notice to: Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity. | Cell Rep | 2024 | 38787722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8493/papers?page=7